HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akiyuki Uzawa Selected Research

Neuromuscular Junction Diseases

1/2021High levels of serum interleukin-6 are associated with disease activity in myasthenia gravis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akiyuki Uzawa Research Topics

Disease

43Myasthenia Gravis
06/2024 - 12/2009
21Neuromyelitis Optica (Devic's Disease)
01/2023 - 12/2009
12Multiple Sclerosis
01/2020 - 12/2009
8Inflammation (Inflammations)
01/2021 - 05/2013
7Autoimmune Diseases (Autoimmune Disease)
01/2024 - 05/2013
7Nervous System Diseases (Neurological Disorders)
04/2022 - 12/2010
6Thymoma (Thymic Carcinoma)
11/2021 - 06/2015
5Disease Progression
01/2024 - 07/2019
3Neoplasms (Cancer)
08/2022 - 01/2016
3Optic Neuritis (Retrobulbar Neuritis)
04/2022 - 01/2011
2Muscle Weakness
01/2024 - 01/2017
2Atrophy
01/2023 - 08/2019
2Neuralgia (Stump Neuralgia)
09/2022 - 01/2011
2Cerebral Infarction
08/2022 - 01/2018
2Demyelinating Diseases (Demyelinating Disease)
02/2021 - 12/2005
2Diabetes Mellitus
01/2021 - 12/2020
2Ischemic Stroke
01/2021 - 12/2020
2Transient Ischemic Attack
01/2021 - 01/2018
2Atherosclerosis
01/2021 - 12/2020
2Myelitis
11/2020 - 06/2013
2Thymus Hyperplasia
11/2016 - 01/2015
1Immune System Diseases (Immune Disorders)
07/2023
1Vascular Remodeling
01/2023
1Seizures (Absence Seizure)
09/2022
1Adenomyosis
08/2022
1Stroke (Strokes)
08/2022
1Brain Infarction
08/2022
1Venous Thrombosis (Deep-Vein Thrombosis)
08/2022
1Inclusion Body Myositis
04/2022
1Muscular Diseases (Myopathy)
04/2022
1Anaphylaxis (Anaphylactic Shock)
02/2022
1Cryptococcal Meningitis
08/2021
1Neuromuscular Junction Diseases
01/2021
1Aspiration Pneumonia
01/2021
1Myocardial Infarction
01/2021
1Chronic Renal Insufficiency
01/2021
1Esophageal Squamous Cell Carcinoma
12/2020
1Colorectal Neoplasms (Colorectal Cancer)
12/2020
1Neuroinflammatory Diseases
11/2020
1Nausea
01/2020
1Vertigo (Positional Vertigo)
01/2020
1Progressive Multifocal Leukoencephalopathy
05/2018

Drug/Important Bio-Agent (IBA)

14Cholinergic ReceptorsIBA
06/2024 - 12/2009
13AutoantibodiesIBA
05/2024 - 07/2015
11AntibodiesIBA
11/2023 - 07/2015
11Interleukin-6 (Interleukin 6)IBA
09/2022 - 12/2009
8Prednisolone (Predate)FDA LinkGeneric
01/2024 - 01/2015
8CytokinesIBA
11/2023 - 12/2010
7Proteins (Proteins, Gene)FDA Link
01/2024 - 12/2005
6Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 01/2009
5Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2024 - 01/2017
5Immunoglobulin G (IgG)IBA
01/2023 - 01/2020
4eculizumabFDA Link
04/2024 - 06/2019
4Myelin-Oligodendrocyte GlycoproteinIBA
01/2023 - 01/2020
4AntigensIBA
08/2022 - 12/2020
4Biomarkers (Surrogate Marker)IBA
01/2022 - 07/2011
3Complement System Proteins (Complement)IBA
04/2024 - 01/2020
3CD40 Ligand (CD40L)IBA
11/2023 - 01/2017
3ChemokinesIBA
04/2022 - 12/2010
3Fingolimod Hydrochloride (FTY720)FDA Link
08/2021 - 01/2018
3SteroidsIBA
01/2021 - 01/2019
3HMGB1 Protein (HMG1)IBA
01/2021 - 05/2013
2glucose-mannose-glucoseIBA
04/2024 - 01/2020
2Phosphotransferases (Kinase)IBA
12/2023 - 11/2023
2MethylprednisoloneFDA LinkGeneric
01/2023 - 07/2019
2Intravenous Immunoglobulins (IVIG)FDA Link
02/2022 - 05/2021
2Complementary DNA (cDNA)IBA
01/2021 - 12/2020
2AlbuminsIBA
01/2018 - 07/2017
2InterleukinsIBA
06/2017 - 12/2009
2myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA
11/2016 - 04/2016
1muskIBA
06/2024
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2024
1Semaphorins (Semaphorin)IBA
05/2024
1ravulizumabIBA
04/2024
1SuspensionsIBA
11/2023
1Indicators and Reagents (Reagents)IBA
06/2023
1LeptinIBA
01/2023
1Growth Differentiation Factor 2IBA
01/2023
1LigandsIBA
01/2023
1interleukin-21 (interleukin 21)IBA
01/2023
1satralizumabIBA
09/2022
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
09/2022
1Monoclonal AntibodiesIBA
09/2022
1PTX3 proteinIBA
01/2022
1B-Cell Activation Factor ReceptorIBA
11/2021
1CXC ChemokinesIBA
11/2021
1Peptides (Polypeptides)IBA
01/2021
1Recombinant ProteinsIBA
01/2021
1ImmunosorbentsIBA
01/2021
1Protein Subunits (Protein Subunit)IBA
01/2020
1Complement Inactivating AgentsIBA
12/2019
1Natalizumab (Tysabri)FDA Link
05/2018

Therapy/Procedure

6Therapeutics
12/2022 - 01/2017
3Activities of Daily Living (ADL)
06/2023 - 12/2019
3Immunotherapy
01/2023 - 12/2022
2Duration of Therapy
08/2019 - 05/2018
1Biological Therapy
01/2023
1Hysterectomy
08/2022
1Blood Component Removal (Apheresis)
02/2022
1Artificial Respiration (Mechanical Ventilation)
01/2021